Opinion · 29 Jun 2025
CommentaryPublished 30 Jun 2021
Hormone Replacement Therapy and Breast Cancer.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Collaborative Group on Hormonal Factors in Breast Cancer has united and reanalysed around 90% of the overall epidemiological proof on the connection between hazard of bosom malignant growth and utilization of chemical substitution treatment (HRT). Individual information on ladies with breast malignancy and 108,411 ladies without bosom malignant growth from in visitations in nations were gathered, checked, and dissected halfway. The principle investigations depend on postmenopausal ladies with a known age at menopause, of who had utilized HRT sooner or later. The middle age at first use was 48 years, and 34% of ever-clients had utilized HRT for a considerable length of time or more. Appraisals of the general danger of bosom malignant growth related with the utilization of HRT were gotten after definition of all investigations by study, age at determination, time since menopause, weight list, equality, and the age a lady was the point at which her first youngster was conceived.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Oncology and Cancer Research.
Opinion · 29 Jun 2025
Molecular Biomarkers for Early Detection and Prognosis of Breast Cancer
Commentary · 29 Jun 2025
Targeted Therapy in Non-Small Cell Lung Cancer: Current Landscape and Future Directions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Oncology and Cancer Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yasmin Nasser”

